Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Clinical trial NCT00305708 · COMPLETED

Trial details

NCT number: NCT00305708
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Congenital Amegakaryocytic Thrombocytopenia Diamond-blackfan Anemia Fanconi Anemia Leukemia Severe Congenital Neutropenia Thrombocytopenia

Start date: 2000-08-01
Primary completion: 2004-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.